School-based Interventions for Test Anxiety in Adolescents

NCT03610542 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2020-09-04

No results posted yet for this study

Summary

This study evaluates the clinical and cost effectiveness of test anxiety as a form of selective prevention for clinical anxiety. Participants will be randomly allocated to cognitive behavioural therapy without booster sessions, cognitive behavioural therapy with two booster sessions, or a no intervention control.

Conditions

Interventions

BEHAVIORAL

Triggers for anxiety

Students learn about different triggers for anxiety, what the signs and indicators of anxiety are, and identify their own triggers for anxiety

BEHAVIORAL

Identifying and challenging negative thoughts

Students learn about the types of unrealistic thoughts that underpin anxiety and how anxiety can be reduced with more realistic thoughts. Students identify their own unrealistic thoughts that contribute to anxiety and what more realistic thoughts can be used.

BEHAVIORAL

Relaxation

Students are taught to relax through (1) breathing exercises, (2) progressive muscle relaxation, and (3) imagery. Student practice these techniques.

BEHAVIORAL

Goal Setting

Students learn how to set goals, monitor goal progress, and check when goals have been achieved. Students then identify their own goals.

BEHAVIORAL

Overcoming avoidance

Students identify ways that they avoid anxiety-provoking situations (e.g., procrastinating exam study). Students develop plans for exposure to anxiety-provoking situations and learn study strategies to build confidence.

Sponsors & Collaborators

  • Wellcome Trust

    collaborator OTHER
  • Manchester University

    collaborator UNKNOWN
  • Leeds University

    collaborator UNKNOWN
  • Liverpool John Moores University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-30
Primary Completion
2023-06-30
Completion
2024-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03610542 on ClinicalTrials.gov